supply of tab/cap darolutamide 300 mg (brand nubeqa, marketed by m/s bayer pharmaceuti cals pvt. ltd.) per unit (item no. 2553a of si 2026-27) [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] - tab/cap darolutamide 300 mg (brand nubeqa, marketed by m/s bayer pharmaceuticals pvt. ltd.) per unit

North Central Railway has invited bids for the supply of tab/cap darolutamide 300 mg (brand nubeqa, marketed by m/s bayer pharmaceuti cals pvt. ltd.) per unit (item no. 2553a of si 2026-27) [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ] - tab/cap darolutamide 300 mg (brand nubeqa, marketed by m/s bayer pharmaceuticals pvt. ltd.) per unit.. Please refer to the tender document for project value and EMD details. Interested bidders can submit applications until 9 October 2026, with the technical opening scheduled for 9 October 2026.